tradingkey.logo
tradingkey.logo
Search

Jupiter Neurosciences Inc

JUNS
Add to Watchlist
1.760USD
-0.100-5.38%
Close 11-13 16:00(ET)
2.32MMarket Cap
LossP/E TTM

Jupiter Neurosciences Inc (JUNS) Stock Price Target & Forecast

Target Price
25.000USD0.00%

JUNS Analyst Recommendation Trends

In the current month, JUNS has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. JUNS average Analyst price target in the last month is 25.000.

2026-11
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
Strong Buy
0
0
0
0
0
0
0
0
Buy
0
0
0
0
0
0
1
1
Hold
0
0
0
0
0
0
0
0
Strong Sell
0
0
0
0
0
0
0
0
Sell
0
0
0
0
0
0
0
0
Total
0
0
0
0
0
0
1
1

JUNS Analyst Rating for Peer Comparison

Updated: Nov 5, 2026
Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Ratings
Analysts
argenx SE
ARGX
10
14
3
0
0
27
Beigene Ltd
ONC
8
19
0
0
0
27
Ionis Pharmaceuticals Inc
IONS
6
16
4
0
0
26
Insmed Inc
INSM
6
18
1
0
0
25
Revolution Medicines Inc
RVMD
10
14
1
0
0
25
Ascendis Pharma A/S
ASND
9
13
1
0
0
23
CRISPR Therapeutics AG
CRSP
4
8
11
0
0
23
Kymera Therapeutics Inc
KYMR
9
12
2
0
0
23
Tempus AI Inc
TEM
4
7
11
0
1
23
Biontech SE
BNTX
4
12
6
0
0
22

Financial Forecasting

Based on analysts' estimates, JUNS EPS is projected to reach -0.050 in FY2026Q3, following reported EPS of -4.079 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.

EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-5.25
-0.05
-0.05
-0.05
0.19
Actual
-0.07
-0.06
-4.08
--
--
Surprise
+98.72%
-16.98%
-8058.30%
--
--

FAQs

What is Jupiter Neurosciences Inc's expected revenue for the next quarter?

Jupiter Neurosciences Inc's expected revenue is 602.00K.

What is Jupiter Neurosciences Inc's price target?

Analysts forecast that Jupiter Neurosciences Inc's price target is USD 25.00, with the highest forecast at USD 25.00 and the lowest forecast at USD 25.00.

How have Jupiter Neurosciences IncJUNS's recent earnings per share performed?

The market expectation was USD -4.08, while Jupiter Neurosciences IncJUNS's earnings per share (EPS) for the previous quarter was USD -0.06. EPS for the next quarter is expected at USD -0.05.

What is the analyst rating for Jupiter Neurosciences Inc?

Based on the ratings of Jupiter Neurosciences Inc's stock from 0 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.